Archives202520242023202220212020201920182017201620152014201320122011 March 27, 2012PRELIMINARY RESULTS ANNOUNCEMENT for the year ended 31 December 2011 Read More February 29, 2012ImmuPharma PLC Appoints Head of Investor Relations Read More November 03, 2011ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More October 21, 2011ImmuPharma regains Lupuzor rights from Cephalon due to Teva merger Read More 1…678
November 03, 2011ImmuPharma’s Lupuzor™ given approval to start phase III and Fast Track designation by the FDA Read More
